Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein.
about
Involvement of claudin-7 in HIV infection of CD4(-) cells.Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidatesBioinformatic analysis of HIV-1 entry and pathogenesis.Antibody potency relates to the ability to recognize the closed, pre-fusion form of HIV EnvV3 loop truncations in HIV-1 envelope impart resistance to coreceptor inhibitors and enhanced sensitivity to neutralizing antibodiesMutations in HIV-1 envelope that enhance entry with the macaque CD4 receptor alter antibody recognition by disrupting quaternary interactions within the trimer.C-terminal tail of human immunodeficiency virus gp41: functionally rich and structurally enigmatic.Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoprotein.Anti-HIV agents targeting the interaction of gp120 with the cellular CD4 receptor.Temporal analysis of HIV envelope sequence evolution and antibody escape in a subtype A-infected individual with a broad neutralizing antibody responseDiscovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolateCD4-independent use of Rhesus CCR5 by human immunodeficiency virus Type 2 implicates an electrostatic interaction between the CCR5 N terminus and the gp120 C4 domain.Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strainsEmergence of CD4 independence envelopes and astrocyte infection in R5 simian-human immunodeficiency virus model of encephalitis.Variations in autologous neutralization and CD4 dependence of b12 resistant HIV-1 clade C env clones obtained at different time points from antiretroviral naïve Indian patients with recent infection.Truncation of the cytoplasmic domain induces exposure of conserved regions in the ectodomain of human immunodeficiency virus type 1 envelope protein.Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate.Rapid progression to simian AIDS can be accompanied by selection of CD4-independent gp120 variants with impaired ability to bind CD4.A variable region 3 (V3) mutation determines a global neutralization phenotype and CD4-independent infectivity of a human immunodeficiency virus type 1 envelope associated with a broadly cross-reactive, primary virus-neutralizing antibody responseImportance of B-cell responses for immunological control of variant strains of simian immunodeficiency virus.Identification of gp120 binding sites on CXCR4 by using CD4-independent human immunodeficiency virus type 2 Env proteins.Structure/Function Studies Involving the V3 Region of the HIV-1 Envelope Delineate Multiple Factors That Affect Neutralization Sensitivity.Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus.Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events.Adaptive mutations in a human immunodeficiency virus type 1 envelope protein with a truncated V3 loop restore function by improving interactions with CD4.Neutralization of human immunodeficiency virus type 1 by sCD4-17b, a single-chain chimeric protein, based on sequential interaction of gp120 with CD4 and coreceptor.An alteration of human immunodeficiency virus gp41 leads to reduced CCR5 dependence and CD4 independence.Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirionsLonger V1V2 region with increased number of potential N-linked glycosylation sites in the HIV-1 envelope glycoprotein protects against HIV-specific neutralizing antibodies.Cell tropism of simian immunodeficiency virus in culture is not predictive of in vivo tropism or pathogenesisHIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation.The role of dynamin in HIV type 1 Env-mediated cell-cell fusion.Vaccine-delivered HIV envelope inhibits CD4(+) T-cell activation, a mechanism for poor HIV vaccine responses.CD4-independent use of the CCR5 receptor by sequential primary SIVsm isolatesConserved changes in envelope function during human immunodeficiency virus type 1 coreceptor switchingMiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency.HIV evolution and escape.Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent.
P2860
Q25257657-C79D0B8D-BF29-411D-B82E-BE53C1309526Q27489000-C80C2437-1FE5-4C5C-B454-5A5A3C786B60Q27693321-80B58008-1FBB-4819-90B1-07BEB5339B4AQ28256508-B29A299B-26EC-4D31-BAB4-F22970318B3CQ28469283-6F382C67-A33F-4B84-B5CE-B61D89F827A5Q30368471-AD08F210-9B80-4713-B507-F849CE779ED0Q30422545-EDA3529E-EADE-40FB-897B-0E4D909220AFQ30454762-AA70D401-A1F0-4D38-BE01-28B505518748Q33223969-C446C0BC-48D2-49ED-851B-C97A2C137368Q33664910-654E2D4D-A67C-4178-AE0C-DFA67ADE950DQ33780620-4251B547-4C9F-495A-9F53-6EAB4C9A317CQ33788874-C14BFD1A-1880-4629-9C97-95E5E6DA753DQ33848876-2CAF5671-DEEA-4D35-8880-2B89A14770D0Q33984243-7A01AFEF-6A56-4C61-8EA1-B6B2653499EDQ33984358-2144B5CC-EDD3-40AB-8EC4-F73CDE3BCCF9Q34057907-4C13624B-26F5-4E77-9727-A4C4396FC9CEQ34203163-2A22A411-86A6-4D0E-AA58-013D617945B4Q34332519-E9D9E726-FAE8-47F1-A5DC-773AC8729D26Q34340428-4B18E986-359D-442C-8835-DD445CF19851Q34342950-E4506772-D545-46ED-9B28-1A8AD87BE076Q34357078-A0D87EA9-5163-44F5-8468-CCC86039B747Q34462440-B1A733FE-7AC2-4D78-8E15-58931352020BQ34465007-FB494923-A69A-4934-B0F5-56031EC15EF0Q34499013-DD0A7730-0BCE-429E-A9A5-C0848DD714C9Q34545719-59CEA25C-F82F-43C4-B145-0A1A20664E04Q34545861-E30D9003-6FB0-419E-AA8E-6DB4394A8632Q34610959-58AF6114-B83F-41AA-95DE-7F912BD11E80Q34756144-1D221C4F-47C3-4ABC-85E3-F5E5A7BA4D64Q34763384-C97E0EC6-4A30-4BAE-999C-102614996231Q34977075-30593922-A00C-4664-85AD-8C9A77F2E7F6Q35077797-9ECD550D-B35F-4AAA-B097-055D9752C752Q35103497-21C18269-B1B9-451E-BD88-D965DA17B8CCQ35113720-3EE20BB0-0DBE-4CCC-A17B-4DE5D5D0C337Q35179370-CC8EEE27-41C9-444B-864B-99A870249BFFQ35750908-2086AAC5-AA9F-4112-AB04-4B14D3D3C5F9Q35946467-F5028617-768C-4CB6-9ABB-7842DF14B87FQ35947621-F1209449-91EF-4AD5-A4AC-B7794D633C00Q36127736-F41C2AB9-3CCB-4120-9D6F-6020543C1A25Q36489903-F6912D29-6AA2-4E9F-A99C-B139105414D5Q36506821-35F212DD-C043-4881-831B-A4AB15485FC0
P2860
Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Relationships between CD4 inde ...... virus type 1 envelope protein.
@ast
Relationships between CD4 inde ...... virus type 1 envelope protein.
@en
type
label
Relationships between CD4 inde ...... virus type 1 envelope protein.
@ast
Relationships between CD4 inde ...... virus type 1 envelope protein.
@en
prefLabel
Relationships between CD4 inde ...... virus type 1 envelope protein.
@ast
Relationships between CD4 inde ...... virus type 1 envelope protein.
@en
P2093
P2860
P1433
P1476
Relationships between CD4 inde ...... virus type 1 envelope protein.
@en
P2093
C C LaBranche
F Baribaud
J Adkinson
T G Edwards
T L Hoffman
P2860
P304
P356
10.1128/JVI.75.11.5230-5239.2001
P577
2001-06-01T00:00:00Z